Seema Shetty joined Talaris Therapeutics in June 2021 as Senior Director, Regulatory Affairs. Seema has extensive experience in drug development having worked in regulatory affairs for 18 years across multiple therapeutic areas during her tenure at Gilead Sciences (infectious diseases), Dendreon (oncology), Acucela (ophthalmology) and most recently, consulting for hematology indications. In her current role, Seema serves as an active member of the Leadership team and is responsible for providing strategic input and execution of regulatory deliverables with a focus on innovative approaches to drug development.
Seema has a bachelors degree in pharmacy from College of Pharmaceutical Sciences, India and postgraduate diploma from Seneca College, Canada.